» Articles » PMID: 29089904

Ion Channel Trafficking: Control of Ion Channel Density As a Target for Arrhythmias?

Overview
Journal Front Physiol
Date 2017 Nov 2
PMID 29089904
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The shape of the cardiac action potential (AP) is determined by the contributions of numerous ion channels. Any dysfunction in the proper function or expression of these ion channels can result in a change in effective refractory period (ERP) and lead to arrhythmia. The processes underlying the correct targeting of ion channels to the plasma membrane are complex, and have not been fully characterized in cardiac myocytes. Emerging evidence highlights ion channel trafficking as a potential causative factor in certain acquired and inherited arrhythmias, and therapies which target trafficking as opposed to pore block are starting to receive attention. In this review we present the current evidence for the mechanisms which underlie precise control of cardiac ion channel trafficking and targeting.

Citing Articles

Ion channel traffic jams: the significance of trafficking deficiency in long QT syndrome.

Mondejar-Parreno G, Moreno-Manuel A, Ruiz-Robles J, Jalife J Cell Discov. 2025; 11(1):3.

PMID: 39788950 PMC: 11717978. DOI: 10.1038/s41421-024-00738-0.


Sorbs2 Deficiency and Vascular BK Channelopathy in Diabetes.

Sun X, Lee H, Lu T Circ Res. 2024; 134(7):858-871.

PMID: 38362769 PMC: 10978258. DOI: 10.1161/CIRCRESAHA.123.323538.


A Novel DLG1 Variant in a Family with Brugada Syndrome: Clinical Characteristics and In Silico Analysis.

dApolito M, Santoro F, Santacroce R, Cordisco G, Ragnatela I, DArienzo G Genes (Basel). 2023; 14(2).

PMID: 36833354 PMC: 9957379. DOI: 10.3390/genes14020427.


In silico analysis of the dynamic regulation of cardiac electrophysiology by K 11.1 ion-channel trafficking.

Meier S, Grundland A, Dobrev D, Volders P, Heijman J J Physiol. 2023; 601(13):2711-2731.

PMID: 36752166 PMC: 10313819. DOI: 10.1113/JP283976.


The Role of Lipids in CRAC Channel Function.

Maltan L, Andova A, Derler I Biomolecules. 2022; 12(3).

PMID: 35327543 PMC: 8944985. DOI: 10.3390/biom12030352.


References
1.
Sanguinetti M, Curran M, Zou A, Shen J, Spector P, Atkinson D . Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996; 384(6604):80-3. DOI: 10.1038/384080a0. View

2.
Rajamani S, Anderson C, Anson B, January C . Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block. Circulation. 2002; 105(24):2830-5. DOI: 10.1161/01.cir.0000019513.50928.74. View

3.
Sanguinetti M, Tristani-Firouzi M . hERG potassium channels and cardiac arrhythmia. Nature. 2006; 440(7083):463-9. DOI: 10.1038/nature04710. View

4.
Lundbaek J, Birn P, Girshman J, Hansen A, Andersen O . Membrane stiffness and channel function. Biochemistry. 1996; 35(12):3825-30. DOI: 10.1021/bi952250b. View

5.
Valdivia C, Tester D, Rok B, Porter C, Munger T, Jahangir A . A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. Cardiovasc Res. 2004; 62(1):53-62. DOI: 10.1016/j.cardiores.2004.01.022. View